← FDA Drug Approvals (Drugs@FDA)

GABAPENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2018-10-16

Drug application

FDA Application #

ANDA211314

Application type

Abbreviated New Drug Application (Generic)

Brand name

GABAPENTIN

Generic name

GABAPENTIN

Active ingredients

GABAPENTIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

STRIDES PHARMA

Manufacturer

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

First approval

2018-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown